Kangmei Pharma | 600518 - Market Capitalization



Kangmei Pharma reported CNY28.14B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Alaunos Therapeutics USD 3M 2M Dec/2024
Avita Medical AUD 335.59M 29.1M Dec/2024
Cspc Pharmaceutical HKD 57.03B 1.39B Mar/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Genomma Lab Internacional MXN 20.49B 4.28B Jun/2025
Hypermarcas BRL 15.23B 1.99B Sep/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
IQVIA Holdings USD 27.26B 3.82B Jun/2025
Jiangsu Hengrui CNY 343.75B 29.9B Jun/2025
Kangmei Pharma CNY 26.2B 2.77B Jun/2025
Moderna USD 10.67B 290M Jun/2025
Organon & Co USD 2.41B 108.26M Sep/2025
Revvity USD 11.53B 1.18B Jun/2025
Sh Fosun Pharma CNY 61.49B 1.29B Jun/2025
Tectonic Therapeutic USD 377M 6M Sep/2025
Viatris USD 10.48B 83.95M Jun/2025
Wuxi Apptec CNY 200.62B 7.42B Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025
Zz Pientze Pharmaceu 120.67B 1.25B Jun/2025